Catalyst Pharmaceuticals
CPRX
#4152
Rank
NZ$4.82 B
Marketcap
NZ$39.27
Share price
-2.68%
Change (1 day)
-0.84%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: NZ$4.82 Billion

As of January 2026 Catalyst Pharmaceuticals has a market cap of NZ$4.82 Billion. This makes Catalyst Pharmaceuticals the world's 4152th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$4.82 B-6.59%
2025NZ$5.16 B13.81%
2024NZ$4.54 B60.23%
2023NZ$2.83 B-7.05%
2022NZ$3.04 B198.67%
2021NZ$1.02 B112.49%
2020NZ$0.48 B-16.56%
2019NZ$0.57 B95.77%
2018NZ$0.29 B-47.87%
2017NZ$0.56 B348.97%
2016NZ$0.12 B-57.63%
2015NZ$0.29 B13.2%
2014NZ$0.26 B103.97%
2013NZ$0.12 B486.48%
2012NZ$21.9 M-46.35%
2011NZ$40.82 M64.05%
2010NZ$24.88 M59.07%
2009NZ$15.64 M-64.12%
2008NZ$43.61 M-22.71%
2007NZ$56.42 M-34.25%
2006NZ$85.81 M

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

NZ$4.95 Billion
by Nasdaq info icon info icon
NZ$4.95 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
NZ$18.52 B 283.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.97 B-17.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$906.17 B 18,672.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.42 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$251.26 B 5,105.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$374.50 B 7,658.26%๐Ÿ‡บ๐Ÿ‡ธ USA